Sign in
4

Changes in Ownership

Travere Therapeutics, Inc. Filed Acc 0001415889-24-024795

Director sold 40,000 shares at an average $14.73 ($589,101)

  • Director acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LYONS GARY A · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-04 Exercise or conversion : show line 1 in the form 10b5-1 +40,000 $10.48 $419,200 91,000 D
2024-10-04 Sale : show line 2 in the form 10b5-1 −21,179 $14.35 $303,874 69,821 D
2024-10-04 Sale : show line 3 in the form 10b5-1 −18,821 $15.15 $285,227 51,000 D
Open-market sales · 40,000 sh · avg $14.73 · $589,101

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-04 Exercise or conversion : show line 4 in the form 10b5-1 Stock option (right to buy) +40,000 0 D
Loading xslF345X05/form4-10042024_111048.xml…